As shown in Table 2, the odds of breast cancer were found to be more than five-fold higher in women with a serum PD-L1 level ≥50 pg/mL than women with a PD-L1 level <50 pg/mL in both African American and Hispanic cohorts based on multivariate analysis adjusted for age and BMI. This evidence concerns the gene CD274 and breast carcinoma.